These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial. Schmidt H, Suciu S, Punt CJ, Gore M, Kruit W, Patel P, Lienard D, von der Maase H, Eggermont AM, Keilholz U, American Joint Committee on Cancer Stage IV Melanoma, EORTC 18951. J Clin Oncol; 2007 Apr 20; 25(12):1562-9. PubMed ID: 17443000 [Abstract] [Full Text] [Related]
5. Dacarbazine with or without oblimersen (a Bcl-2 antisense oligonucleotide) in chemotherapy-naive patients with advanced melanoma and low-normal serum lactate dehydrogenase: 'The AGENDA trial'. Bedikian AY, Garbe C, Conry R, Lebbe C, Grob JJ, Genasense Melanoma Study Group. Melanoma Res; 2014 Jun 20; 24(3):237-43. PubMed ID: 24667300 [Abstract] [Full Text] [Related]
6. Oblimersen in the treatment of metastatic melanoma. Tarhini AA, Kirkwood JM. Future Oncol; 2007 Jun 20; 3(3):263-71. PubMed ID: 17547520 [Abstract] [Full Text] [Related]
10. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma. Djukanovic D, Hofmann U, Sucker A, Rittgen W, Schadendorf D. Anticancer Res; 2000 Mar 08; 20(3B):2203-7. PubMed ID: 10928178 [Abstract] [Full Text] [Related]
11. Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma. Guida M, Riccobon A, Biasco G, Ravaioli A, Casamassima A, Freschi A, Palma MD, Galligioni E, Nortilli R, Chiarion-Sileni V, Picozzo J, Romanini A, Nanni O, Ridolfi R, Italian Melanoma Intergroup (IMI). Melanoma Res; 2006 Aug 08; 16(4):317-23. PubMed ID: 16845327 [Abstract] [Full Text] [Related]
19. Unexpected clinical outcome in a patient with liver and brain metastasis from melanoma. Nuzzo C, Zeuli M, Ferraresi V, Ciccarese M, Pelligrini D, Cognetti F. Anticancer Res; 2008 Apr 08; 28(2B):1429-31. PubMed ID: 18505091 [Abstract] [Full Text] [Related]
20. Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial. Ott PA, Chang J, Madden K, Kannan R, Muren C, Escano C, Cheng X, Shao Y, Mendoza S, Gandhi A, Liebes L, Pavlick AC. Cancer Chemother Pharmacol; 2013 Jan 08; 71(1):183-91. PubMed ID: 23064957 [Abstract] [Full Text] [Related] Page: [Next] [New Search]